BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX today launched new versions of its Archer™ Suite of software programs, consisting of Analysis 3.1, Assay Designer 2.0 and Quiver 1.0.2.
* The bioinformatics platform, Archer™ Analysis 3.1, now supports automated sequence analysis as soon as sequencing completes, improving turnaround time and enabling researchers to accurately call known or novel genomic alterations even faster than before.
A web-based portal where customers design gene fusion assays, Archer™ Assay Designer 2.0 now enables the creation of multiplex gene fusion assays by modifying existing, optimized catalog panels. Archer fusion assays are targeted next-generation sequencing assays that utilize proprietary Anchored Multiplex PCR (AMP™) enrichment chemistry.
Help employers find you! Check out all the jobs and post your resume.
